IgD-Fc-Ig fusion protein, a new biological agent, inhibits T cell function in CIA rats by inhibiting IgD-IgDR-Lck-NF-κB signaling pathways.

MLA

Han, Le, et al. “IgD-Fc-Ig Fusion Protein, a New Biological Agent, Inhibits T Cell Function in CIA Rats by Inhibiting IgD-IgDR-Lck-NF-ΚB Signaling Pathways.” Acta Pharmacologica Sinica, vol. 41, no. 6, June 2020, pp. 800–12. EBSCOhost, https://doi.org/10.1038/s41401-019-0337-2.

APA

Han, L., Zhang, X.-Z., Wang, C., Tang, X.-Y., Zhu, Y., Cai, X.-Y., Wu, Y.-J., Shu, J.-L., Wang, Q.-T., Chen, J.-Y., Chang, Y., Wu, H.-X., Zhang, L.-L., & Wei, W. (2020). IgD-Fc-Ig fusion protein, a new biological agent, inhibits T cell function in CIA rats by inhibiting IgD-IgDR-Lck-NF-κB signaling pathways. Acta Pharmacologica Sinica, 41(6), 800–812. https://doi.org/10.1038/s41401-019-0337-2

Chicago

Han, Le, Xian-Zheng Zhang, Chen Wang, Xiao-Yu Tang, Yue Zhu, Xiao-Yu Cai, Yu-Jing Wu, et al. 2020. “IgD-Fc-Ig Fusion Protein, a New Biological Agent, Inhibits T Cell Function in CIA Rats by Inhibiting IgD-IgDR-Lck-NF-ΚB Signaling Pathways.” Acta Pharmacologica Sinica 41 (6): 800–812. doi:10.1038/s41401-019-0337-2.